Olympus America and Germany-based Carl Zeiss Microscopy have entered into a nonexclusive global licensing agreement through which Zeiss can have access to a wide range of patent portfolio under Olympus for virtual microscopy and digital pathology. Terms and conditions of the agreement have not been disclosed.
The patents within the licensing deal include methods and equipment for developing, storing and delivering virtual microscopy slides. By using this technology, users can view and share high-resolution virtual microscopy images via internet.
According to the Executive Director Business Development, Scientific Equipment Group of Olympus Corporation of the Americas, Brad Burklow, the worldwide adoption of digital slide scanning will expand into new scientific and medical applications. Olympus owns several important patents in this area, and it is critical to permit a wide access to these technologies for advancing pathology and medical research. By improving and handling these technologies, better healthcare services can be provided for patients across the globe.
Dr. Bernhard Ohnesorge, Member of the Board and also the GM of BioSciences Division at Carl Zeiss Microscopy, stated that digital data handling has become a key driver in the development of new microscopy. When the company’s research microscope systems are incorporated with the virtual slide functionality, customers can efficiently explore new scientific approaches. This will enable researchers to better understand the origin of challenging diseases.